CVX-096

PF-04856883 · Pfizer

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for CVX-096, covering 2015-07-31 to 2017-04-18. Get the full timeline:

Most recent: Clinical Trial Update: A Safety and Pharmacokinetic Study of CVX-096 in Type 2 Diabetics [Phase 1]